Saunders: Allergan Will Remain in Ophthalmology
Brent Saunders, chairman, president, and CEO, says Allergan has no plans to exit ophthalmology. The pending loss of Restasis will require some cuts, but the company remains committed to the sector and acquiring innovative businesses.